Researchers at Elon Musk’s company Neuralink have launched the initial study of the impact of brain-computer interfaces (BCIs) on humans, with the aim of exploring their potential to treat individuals paralyzed by spinal cord injuries or amyotrophic lateral sclerosis (ALS).
BCIS systems have received the attention of world leaders in technology and medicine since they were adopted by Elon Musk, as these systems can interpret and translate brain signals, allowing control of external devices without physical intervention.
According to For the blog post Published by the company on September 19, the preliminary study consists of three main components:
Slide N1: This chip is surgically implanted inside the brain, and can capture and transmit neural activity.
According to the publication, the chip records neural activity on its 1,024 electrodes, distributed over 64 threads, each of which is as thin as a human hair.
N1 chip. Source
Robot R1: The robot is used in performing the previous surgical procedure, as this robot is specially designed to place the N1 chip threads specifically in the intended area of the brain.
N1 SIM user applicationNeuralink launched the application with the aim of decoding the user’s intentions from the signals picked up by the N1 implant, allowing users to use computing devices using only their thoughts.
In addition to the above, the publication indicated that the study has specific criteria, as only participants who were paralyzed due to spinal cord injuries or amyotrophic lateral sclerosis (ALS) are accepted, provided that they have been paralyzed for at least a year without seeing any improvement, and that They must be at least 22 years old. Infected people must also have a constant caregiver.
Related articles: New AI model “AlphaMissense” may change the future of genetics and what we know about genetic mutations
The study will extend for six years, and will be divided into different phases, as it will include an initial study lasting approximately 18 months that includes home and medical visits, in addition to regular research sessions on the effects of the BCI system on patients, and then a long-term follow-up lasting for five years.
It should be noted that Neuralink has I got it in late May Obtained approval from the US Food and Drug Administration (FDA) to conduct “human” experiments using a brain chip.
Because BCI systems are more or less a way to integrate humans and machines, they remain an interesting topic of discussion in both the scientific and ethical fields. For this reason, the results of the preliminary study will provide invaluable insights into BCI applications and their potential limitations.
2023-09-21 10:47:37
#Neuralink #announces #start #initial #trials #brain #chip #humans
